Povidone-Iodine is an antiseptic used to kill bacteria and germs on the skin before surgery or to prevent infection in minor cuts, scrapes, and wounds.[2] Betadine is currently approved and in use across 25 indications[4].[1]
Betadine is one of 263 small molecule programs targeting Acanthamoeba keratitis. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
706 competitors in Breast Cancer
Betadine
Lexiscan
Voltaren
Methylthioninium Chloride
Duragesic
Sporanox
Tricor
Rilvegostomig
Vfend
Ablavar
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Nov 29, 1985
E-Z SCRUB 201
NDA NDA019240
Dec 17, 1986
BETADINE
NDA NDA018634
Jan 7, 1987
E-Z SCRUB 241
NDA NDA019476
Mar 31, 1989
POVIDONE IODINE
NDA NDA019522
Jul 25, 1989
E-Z PREP
NDA NDA019382
Sources
Details